BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 20, 2002
View Archived Issues
Saegis Nearing End Of Phase II While Still Using Series A Cash
As the baby boomers age, many will face problems with memory they used to associate with their parents and grandparents. (BioWorld Today)
Read More
Tragen Seeks Funding, Partners For Phase II Cancer Compound
Read More
Anti-Angiogenic Drug, VEGF-Trap By Name, Most Potent Ever Seen,' Scores In Preclinical Mouse Tests
Read More
Shares Of OSI, ImClone Take Hit On AstraZeneca Results
Read More
Other News To Note
Read More